Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma [Phase 2]
A Phase 2 clinical trial is assessing the safety and efficacy of sacituzumab tirumotecan in combination with pucotenlimab for advanced chola…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
A French multicenter observational retrospective study aimed at characterizing rare primary liver cancers, currently recruiting, including s…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder [Phase 1]
A Phase 1 study evaluating DKN-01 in combination with gemcitabine and cisplatin for biliary tract cancers has completed (completion status r…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics reports termination of a Phase I/II autologous TCR-T cell trial across several solid tumors. The study focused on HLA t…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) [Phase 2]
A Phase II clinical trial evaluating the combination of durvalumab (PD-L1 inhibitor) and olaparib (PARP inhibitor) in patients with advanced…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Streamlining Radioembolization for CCC and Metastatic Liver Cancer
An ongoing study evaluating streamlined radioembolization approaches for cholangiocarcinoma and metastatic liver cancer (including metastati…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma [Phase 2]
Phase 2 clinical trial update evaluating ABC294640 (Opaganib) alone and in combination with hydroxychloroquine sulfate in advanced cholangio…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. [Phase 2]
Phase 2 clinical trial evaluating durvalumab with tremelimumab, with or without paclitaxel, for advanced biliary tract cancer after platinum…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer [NA]
This clinical trial update describes the HepQuant study at Montefiore Medical Center evaluating blood-based biomarkers and quantitative MR i…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid [NA]
This document reports that Washington University School of Medicine is implementing a randomized controlled trial to evaluate an expanded we…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Targeted Navigation in Hepatocellular Carcinoma (HCC) [NA]
A University of Miami-sponsored clinical trial is currently recruiting to study targeted navigation approaches in hepatocellular carcinoma, …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator
A clinical trial registry entry for the Spanish Registry of Direct Cholangiopancreatoscopy by a single operator, sponsored by Germans Trias …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) [NA]
A Washington University School of Medicine trial (WU-PE-CGS) is currently recruiting participants for cholangiocarcinoma, multiple myeloma, …
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors [Phase 2]
Phase 2 trial evaluating QL1706 in combination with lenvatinib and GEMOX as first-line therapy for unresectable biliary tract tumors.
-
CLINICAL_TRIALS other · 2025-07-10Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating adoptive transfer of tumor infiltrating lymphocytes (TIL) for biliary tra…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
This clinical trial update reports the termination of a feasibility study evaluating multi-platform profiling of resected biliary tract canc…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial evaluating BL-B01D1 in combination with a PD-1/PD-L1 monoclonal antibody for advanced biliary tract cancer is curre…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal aerosolized nanoliposomal irinotecan (Nal-IRI) for peritoneal carcinomatosis from gastrointestinal …
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas
This clinical trial update outlines a study using proteomic profiling to differentiate pancreatic adenocarcinoma from biliary adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) [Phase 2]
Phase 2 clinical trial update evaluating durvalumab and tremelimumab in combination with propranolol and chemotherapy for advanced hepatopan…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors [Phase 1]
A Phase 1 trial update for KJ015 in HER2-expressing solid tumors shows the study is not yet recruiting.
-
CLINICAL_TRIALS other · 2025-06-25Clinical Trial Update: FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) [Phase 1]
A Phase 1 dose-escalation trial of Lu-177-labeled PNT6555 (FRONTIER) for selected solid tumors assessing safety, tolerability and dosimetry;…